Navigation Links
Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time
Date:7/28/2011

class="discStyle" type="disc">
  • On a US GAAP basis, net cash provided by operating activities was $284 million (Q2 2010: $284 million).

    • Non GAAP net debt at June 30, 2011 was $972 million (December 31, 2010: $531 million), an increase of $441 million, as the net cash provided by operating activities in H1 2011 and existing cash resources were used to fund the acquisition of Advanced BioHealing Inc. ("ABH"), other capital expenditure, the dividend payment and the purchase of shares by the Employee Share Ownership Trust ("ESOT").

    2011 OUTLOOK


    The strong first half performance has further underpinned our confidence in meeting increased market consensus for 2011 earnings. This includes absorbing the marginal dilution of the acquisition of ABH.

    For the full year we expect to see strong product sales growth, and royalty and other revenues combined to be down 10% compared to 2010. Taken together, year on year growth of total revenues in the second half is expected to be marginally lower than the rate of 22% seen in the first half.

    Gross margins are expected to be marginally diluted in the second half as a result of the inclusion of ABH, although gross margins for the full year should still be in line with those recorded in 2010.

    As we have previously indicated, we have identified significant opportunities for future growth by advancing our pipeline and continuing the international expansion of our portfolio. Combined R&D and SG&A, which was set to increase by 13% is now expected to increase in the full year by around 20% year on year. This reflects the inclusion of ABH's cost base (representing an increase in our 2011 full year cost guidance of 5%) and our view of the likely impact of foreign exchange movements on our R&D and SG&A plans in 2011.

    We continue to expect our Non GAAP effective tax rate to be between 22 and 24%.

    Overall, the o
    '/>"/>

    SOURCE Shire plc
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

    Related biology technology :

    1. Neogen Reports 27% Increase in Quarterly Net Income
    2. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
    3. Microbix Has Best-Ever Quarterly Sales
    4. Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled
    5. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
    6. Shires Replenished Portfolio Drives Excellent Quarterly Performance
    7. Quest Diagnostics Declares Quarterly Cash Dividend
    8. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
    9. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
    10. Abbott Declares 343rd Consecutive Quarterly Dividend
    11. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Pittsburgh, PA (PRWEB) January 15, 2014 The ... Company, publisher of Food Safety Tech , an e-Journal ... has signed an agreement for the second year for the ... with Pittcon 2014. The partnership provides that the registration fee ...
    (Date:1/15/2014)... JOSE, California , January 15, 2014 ... cancer, today announced the appointment of Thomas C Reynolds MD, ... 20 years, development experience gained in the biotechnology industry, most ... "I am delighted to welcome Tom at this transformative time ...
    (Date:1/15/2014)... More than 5 million Americans are ... 3 seniors will die with Alzheimer’s or another dementia, ... have shocked many Americans into looking for ways to ... tragic age-related cognitive disorders. Jonathan Weisman, president of Biohack ...
    (Date:1/15/2014)... Arizona (PRWEB) January 15, 2014 2013 ... for Scottsdale’s Brain State Technologies®. They saw continued independent ... Medical Center who were awarded a $1 million grant ... published in “Brain and Behavior” a peer reviewed journal, ...
    Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
    ... Chimerix, Inc., a,biotechnology company developing orally available antiviral ... and multi-dose Phase I,study of CMX001 in healthy volunteers. ... for multiple dsDNA infections. The Company has,initiated the ... "The safety and high oral ...
    ... 6 Biopharmaceutical Company Kiadis,Pharma focused on the ... of bone marrow transplantation, announces today the appointment ... Dr. Egeler is a global,leading pediatric bone marrow ... He brings,to Kiadis Pharma over more than 20 ...
    ... Jan. 5 Nektar Therapeutics,(Nasdaq: NKTR ) ... to present at the upcoming 27th Annual J.P. Morgan ... Hotel on Tuesday,January 13, 2009 at 10:00 a.m. Pacific ... The presentation will be accessible via a Webcast ...
    Cached Biology Technology:Chimerix Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001 2Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer 2
    (Date:4/17/2014)... marrow need to produce hydrogen sulfide in order to ... new study from the Center for Craniofacial Molecular Biology ... , Professor Songtao Shi, principal investigator on the project, ... cells governs the flow of calcium ions. The essential ... in osteogenesis, or the creation of new bone tissue, ...
    (Date:4/17/2014)... Rajendra Singh Thursday as a "Champion of Change" ... deployment in the residential, commercial and industrial sectors. ... Electrical and Computer Engineering and director of Clemson,s ... hero leading the charge across the country to ... and driving policy changes at the local level ...
    (Date:4/17/2014)... Europe, Asia and the United States are spreading across ... native honeybee populations at this time, according to an ... Nosema microsporidia and Varroa mites., ... these invasive pests, which suggests to us that the ... the United States currently are not necessary in East ...
    Breaking Biology News(10 mins):White House honors Clemson professor as 'Champion of Change' for solar deployment 2East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
    ... This release is available in Spanish . ... sort through the jumbled genetics of Echinacea , the ... inflammation, and other human ailments. Only a few ... and plant breeders would like to know whether other types ...
    ... not have a mouth, but they still need to ... - known as endocytosis - is affected, it can ... and diabetes. In cooperation with the Center for Information ... University of Technology, scientists from the Max Planck Institute ...
    ... announcement by the United States that it will support ... and the ocean conservation organization called for international support ... well as for eight shark species proposed for similar ... the focus of the upcoming Convention on International Trade ...
    Cached Biology News:Exploring Echinacea's enigmatic origins 2A fingerprint for genes 2A fingerprint for genes 3A fingerprint for genes 4SeaWeb applauds US decision to support bluefin tuna trade protection 2
    Applications: Western blotting Stability: Room temperature, indefinitely ...
    ... Rabbit Antibody to ARG. Vasopressin ... vasopression peptide. Cells are found in ... fibers are found throughout the hypothalmus ... perfused tissue. Immunogen: ...
    CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
    ...
    Biology Products: